Clinical Trial Update: Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II trial evaluating tivantinib with FOLFOX for advanced solid tumors including metastatic adenocarcinoma of the distal esophagus, gastroesophageal junct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)
• tivantinib (tivantinib)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Malignant Solid Tumour, Gastroesophageal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-11-23